HC Wainwright & Co. Assumes Reneo Pharmaceuticals at Buy, Announces Price Target of $31
HC Wainwright & Co. analyst Gobind Singh assumes Reneo Pharmaceuticals (NASDAQ:RPHM) with a Buy rating and announces Price Target of $31.
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle platform.
Reneo Pharmaceuticals Q2 EPS $(0.50) Down From $(0.43) YoY
Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.50) per share. This is a 16.28 percent decrease over losses of $(0.43) per share from the same period last year.
Recap Of Tuesday’s Biotech Catalysts – End of The Day Summary
European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg…
Reneo Pharmaceuticals Says Metabolic Disorder Program To Enter Next Stage Of Development
Reneo Pharmaceuticals Inc (NASDAQ:RPHM) has reported results from the REN001 long-chain fatty acid oxidation disorders (LC-FAOD) study and provided additional development…
52 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247 million.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
SVB Leerink Maintains Outperform on Reneo Pharmaceuticals, Lowers Price Target to $15
SVB Leerink analyst Joseph Schwartz maintains Reneo Pharmaceuticals (NASDAQ:RPHM) with a Outperform and lowers the price target from $25 to $15.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 109 companies set new 52-week lows.